Rocket Pharmaceuticals in-27RCKTWPreferred / convertible
13F holders, Q1 2025 (March 31)13holders +3
3new positions
0sold out
1famous investor
$0.15avg. 13F price*
At the end of Q1 2025, 13 institutions reported holding Rocket Pharmaceuticals in-27 (RCKTW) in their 13F filings, up 3 from Q4 2024. 3 opened new positions and 0 sold out. The largest holders were Boothbay Fund Management, LLC ($246K), Walleye Capital LLC ($31K) and Sio Capital Management, LLC ($17K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Rocket Pharmaceuticals in-27
- CUSIP
- 77313F114
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $7K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 138,701 shares bought and 26,075 shares sold, net +112,626 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Boothbay Fund Management, LLC | — | No change | 36,912 | $246K |
| Walleye Capital LLC | — | Reduce -0.9% | 665,969 | $31K |
| Sio Capital Management, LLC | — | No change | 400,000 | $17K |
| RTW Investments, LP | — | No change | 350,000 | $16K |
| Citadel Advisors | — | Reduce -6.0% | 317,303 | $15K |
| Susquehanna International Group, LLP | — | New | 119,971 | $6K |
| Silverarc Capital Management, LLC | — | No change | 104,828 | $5K |
| Walleye Trading LLC | — | No change | 83,991 | $4K |
| LMR Partners LLP | — | No change | 75,731 | $4K |
| Affinity Asset Advisors, LLC | — | No change | 75,000 | $4K |
| Virtu Financial LLC | — | New | 18,630 | $1K |
| Ancora Advisors LLC | — | No change | 6,000 | $282 |
| Clear Street LLC | — | New | 100 | $5 |
"% of holder's portfolio" is RCKTW's weight in each manager's 13F, not the share of Rocket Pharmaceuticals in-27 the manager owns.